Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood (Lead / Corresponding author), Grant N. Wheeler

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)
    143 Downloads (Pure)

    Abstract

    [This corrects the article DOI: 10.18632/oncotarget.23378.].

    Original languageEnglish
    Pages (from-to)36645
    Number of pages1
    JournalOncotarget
    Volume9
    Issue number93
    Publication statusPublished - 27 Nov 2018

    Fingerprint

    Dive into the research topics of 'Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth'. Together they form a unique fingerprint.

    Cite this